Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Blueprint Medicines Corp (BPMC)

Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Blueprint Medicines Corp 45 SIDNEY STREET CAMBRIDGE MA 02139 USA

www.blueprintmedicines.com P: 617-374-7580

Description:

Blueprint Medicines Corporation is a biopharmaceutical company focused on developing the potentially transformational precision medicines to address patients with genomically defined cancers and rare diseases.

Key Statistics

Overview:

Market Capitalization, $K 5,593,577
Enterprise Value, $K 5,761,107
Shares Outstanding, K 62,617
Annual Sales, $ 249,380 K
Annual Net Income, $ -506,980 K
Last Quarter Sales, $ 138,160 K
Last Quarter Net Income, $ -49,990 K
EBIT, $ -355,960 K
EBITDA, $ -361,760 K
60-Month Beta 0.58
% of Insider Shareholders 4.21%
Float, K 59,981
% Float 95.79%
Short Volume Ratio 0.48

Growth:

1-Year Return 77.17%
3-Year Return -14.70%
5-Year Return 24.25%
5-Year Revenue Growth 460.15%
5-Year Earnings Growth -55.29%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.80 on 08/01/24
Next Earnings Date 10/24/24
Earnings Per Share ttm -6.14
EPS Growth vs. Prev Qtr 39.39%
EPS Growth vs. Prev Year 63.47%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BPMC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -157.30%
Return-on-Assets % -34.49%
Profit Margin % -203.30%
Debt/Equity 1.21
Price/Sales 21.97
Price/Cash Flow N/A
Price/Book 17.07
Book Value/Share 5.06
Interest Coverage -0.71
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar